Health Care
Latest
-
CRFB's Plan to Offset Upcoming Policies
Read moreCongress and the President need to prep for some important upcoming fiscal moments, and CRFB has a plan to help them do just that. The Paying for... -
New CBO Estimates Set the Stage for "Doc Fix" Discussions
Read moreFollowing a final rule issued by the Centers for Medicare and Medicaid Services (CMS), CBO has updated its estimate of various "doc fix" policies to... -
The PREP Plan: Paying for Reform and Extension Policies
Read moreIn the coming months, Congress and the President will face a number of important decisions with significant fiscal implications. Specifically, they... -
Gene Steuerle: Pushing on Air in a Balloon--Health Cost Growth and $1,000 Pills
Read moreDr. Eugene (Gene) Steuerle is the Richard B. Fisher chair and Institute Fellow at the Urban Institute and a member of the Committee for a Responsible... -
Lame Duck To-Do (and Don't) List
Read moreWith the 2014 midterm elections mostly in the books, the current Congress will return from weeks of campaigning to finish some remaining items before... -
Another Way to Look at the Medicare Slowdown
Read moreA recent Health Affairs piece from CRFB's Loren Adler and Adam Rosenberg showed that the prescription drug benefit, Part D, has been responsible for a... -
CBO Report Parses the Reasons for Part D's Slow Growth
Read moreThe last few months have seen a number of new ideas to save money in Part D of Medicare by encouraging more efficient use of drugs by prescription... -
How CBO Accounts for Anti-Fraud Efforts
Read moreFraud -- along with the closely related waste and abuse -- is too often cited as a big factor affecting our high deficits, even though this is not the... -
Medicare's Slowdown: A Story About Part D
Read moreIn a Health Affairs blog post, CRFB's Loren Adler and Adam Rosenberg find that most of the recent slowdown in Medicare's costs is attributable to the... -
Could Arbitration Help Control Medicare Part D Costs?
Read moreMedicare Part D costs have leveled off in recent years as pharmaceutical innovation has slowed and a number of blockbuster drugs lost patent... -
Is the 340B Program Living Up to Expectations?
Read moreThe 340B Drug Pricing Program, enacted in 1992, gives hospitals and other providers serving disproportionately low-income populations the ability to... -
How Medicare Part D's Low-Income Subsidy Could Work Better
Read moreDuring the recent slowdown in Medicare spending, the prescription drug portion of the program, Part D, has been the lead actor in the story. The...